Please login to the form below
Merz acquire BioForm Medical
Merz Pharma have agreed to acquire BioForm Medical for $253m, expanding its presence in cosmetic pharmaceuticals
Merz Pharma Group have agreed to acquire BioForm Medical Inc (BFRM) for $253m, expanding its cosmetic pharmaceuticals portfolio. The privately held German pharmaceutical company already has a presence in anti-ageing skincare with their product Belotero - the world's first monophasic hyaluronic acid dermal filler with patented CPM technology.
Merz will pay $5.45 per BioForm share, a 60 per cent premium to the company's Thursday closing price.
BioForm, which went public in late 2007, specialises in injectable drugs to improve the appearance of the skin, including treatment of wrinkles and folds, as well as varicose veins. The company is non profitable, though sales have been improving and last November BioForm narrowed its loss forecast for its fiscal year ending June 30.
Share
Related Hub content
Featured jobs
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Scientific Team Lead
-
Competitive Salary
-
Associate Medical Director
-
Salary TBC
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Account Manager, Healthcare Advertising
-
Salary TBC
- Experienced Editor, London, Medical Communications
-
Competitive package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Director Healthcare PR Communications
-
Salary TBC
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Account Director – Global Healthcare PR
-
Salary TBC
-
Associate Medical Director
-
Highly Competitive
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
Account Director - Digital
-
Great salary and benefits
-
Account Director
-
Negotiable
Subscribe to our email news alerts
- AZ and Clovis PARP inhibitors show their mettle at ESMO
- AZ and Medicines Catapult collaborate on innovative sound tech in drug discovery
- Dynavax is ‘deal-ready’ after solid ESMO data; analyst
- Artificial intelligence in healthcare
- Shire’s angioedema drug Takhzyro recommended in Europe
- Cuttsy+Cuttsy launch their latest patient e-book
PMHub
Swordfish Advertising
At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe's leading hub for life sciences innovation...
Quick links
Infographics
